Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.7B |
| 2 |
Microsoft
MSFT
|
+$660M |
| 3 |
ExxonMobil
XOM
|
+$621M |
| 4 |
Apple
AAPL
|
+$520M |
| 5 |
UnitedHealth
UNH
|
+$431M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$957M |
| 2 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$477M |
| 3 |
GE Aerospace
GE
|
+$377M |
| 4 |
AEL
American Equity Investment Life Holding Company
AEL
|
+$271M |
| 5 |
WIRE
Encore Wire Corp
WIRE
|
+$200M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.67% |
| 2 | Financials | 16.95% |
| 3 | Industrials | 12.44% |
| 4 | Consumer Discretionary | 10.5% |
| 5 | Healthcare | 10.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2326
Li Auto
LI
$13.3B
| $8.5M | ﹤0.01% |
475,303
-14,602
| -3% | -$352K |
|
2327
QuantumScape Corp
QS
$3.39B
| $8.49M | ﹤0.01% |
1,726,158
-92,432
| -5% | -$515K |
|
2328
Friedman Industries
FRD
$264M
| $8.48M | ﹤0.01% |
561,702
+1,591
| +0.3% | +$28.7K |
|
|
SFIX
2329
Stitch Fix
SFIX
$558M
| $8.48M | ﹤0.01% |
2,042,924
-339,743
| -14% | -$920K |
|
2330
AnaptysBio
ANAB
$1.64B
| $8.42M | ﹤0.01% |
335,934
-133,926
| -29% | -$3.12M |
|
2331
Edgewise Therapeutics
EWTX
$4.88B
| $8.42M | ﹤0.01% |
467,507
+168,219
| +56% | +$2.93M |
|
2332
Kewaunee Scientific
KEQU
$103M
| $8.38M | ﹤0.01% |
177,548
+6,132
| +4% | +$232K |
|
2333
Crawford & Co Class A
CRD.A
$630M
| $8.37M | ﹤0.01% |
968,933
-12,165
| -1% | -$113K |
|
2334
argenx
ARGX
$54B
| $8.34M | ﹤0.01% |
19,388
+1,438
| +8% | +$550K |
|
2335
Haleon
HLN
$43.8B
| $8.32M | ﹤0.01% |
1,007,458
+24,673
| +3% | +$206K |
|
2336
Parke Bancorp
PKBK
$402M
| $8.31M | ﹤0.01% |
477,549
+22,374
| +5% | +$366K |
|
2337
HBT Financial
HBT
$1.31B
| $8.3M | ﹤0.01% |
406,456
+26,135
| +7% | +$498K |
|
2338
Forrester Research
FORR
$225M
| $8.2M | ﹤0.01% |
480,044
-65,065
| -12% | -$1.19M |
|
2339
Cytek Biosciences
CTKB
$545M
| $8.17M | ﹤0.01% |
1,465,122
+89,615
| +7% | +$538K |
|
2340
Skyward Specialty Insurance
SKWD
$2.55B
| $8.15M | ﹤0.01% |
+225,280
| New | +$8.17M |
|
|
GOOD
2341
Gladstone Commercial Corp
GOOD
$587M
| $8.1M | ﹤0.01% |
567,878
+14,452
| +3% | +$201K |
|
2342
Televisa
TV
$1.45B
| $8.08M | ﹤0.01% |
2,915,731
-30,005
| -1% | -$92K |
|
2343
Cytokinetics
CYTK
$10.7B
| $8.05M | ﹤0.01% |
148,561
+32,372
| +28% | +$1.95M |
|
2344
Sasol
SSL
$7.06B
| $7.97M | ﹤0.01% |
1,047,270
-14,490
| -1% | -$107K |
|
2345
Jakks Pacific
JAKK
$301M
| $7.96M | ﹤0.01% |
444,488
+102,155
| +30% | +$2.02M |
|
|
XRN
2346
Chiron Real Estate Inc
XRN
$464M
| $7.93M | ﹤0.01% |
174,599
+1,335
| +0.8% | +$58K |
|
2347
Artesian Resources
ARTNA
$351M
| $7.93M | ﹤0.01% |
225,400
-7,613
| -3% | -$276K |
|
|
MODV
2348
DELISTED
ModivCare
MODV
| $7.91M | ﹤0.01% |
301,633
-48,936
| -14% | -$1.24M |
|
2349
The RMR Group
RMR
$324M
| $7.91M | ﹤0.01% |
349,912
-7,408
| -2% | -$173K |
|
2350
AstroNova
ALOT
$226M
| $7.89M | ﹤0.01% |
510,969
-2,892
| -0.6% | -$49.4K |
|
Similar funds
Dimensional Fund Advisors's Q2 2024 Portfolio in Review
As of Q2 2024, Dimensional Fund Advisors held 3,454 positions worth $383B, up 3.7% from $369B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Dimensional Fund Advisors deployed $16B of net new capital in Q2 2024, opening 67 new positions and adding to 1,988 existing holdings. Its largest new stake was GE Vernova: 1,030,545 shares worth $177M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 19% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Broadcom, an estimated $957M trimmed.
- Dimensional Fund Advisors's largest Q2 2024 buy was GE Vernova: 1,030,545 shares worth $177M.
- Dimensional Fund Advisors added most to NVIDIA in Q2 2024, an estimated $1.7B increase.
- Dimensional Fund Advisors's biggest Q2 2024 reduction was Broadcom, cutting an estimated $957M.
- Dimensional Fund Advisors fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $477M.
- Dimensional Fund Advisors's ten largest holdings make up 16% of its $383B portfolio in Q2 2024.
- Dimensional Fund Advisors opened 67 new positions and closed 81 in Q2 2024.
- Dimensional Fund Advisors's portfolio value rose 3.7% quarter-over-quarter to $383B.
Based on Dimensional Fund Advisors's 13F filing for Q2 2024, filed 9 Aug 2024.